Tower Research Capital LLC (Trc) Aldeyra Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,622 shares of ALDX stock, worth $18,363. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,622
Previous 7,513
51.79%
Holding current value
$18,363
Previous $28,000
35.71%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding ALDX
# of Institutions
143Shares Held
39.9MCall Options Held
344KPut Options Held
71.7K-
Knoll Capital Management, LLC Miami, FL5.48MShares$27.8 Million15.99% of portfolio
-
Perceptive Advisors LLC New York, NY5.22MShares$26.5 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$18.2 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.9MShares$9.63 Million1.4% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $296M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...